5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Valvuloplasty
Valvuloplasty is a medical procedure designed to treat valvular heart disease, a condition characterized by dysfunction or narrowing of the heart valves. During valvuloplasty, a catheter equipped with a deflated balloon is threaded through blood vessels to the heart valve that requires intervention. Once in position, the balloon is inflated to widen the narrowed valve, improving blood flow and alleviating symptoms associated with valvular disorders. This minimally invasive procedure is often considered as an alternative to traditional open-heart surgery, offering reduced recovery times and less postoperative discomfort. Valvuloplasty has proven to be an effective intervention for select cases of valvular heart disease, providing patients with a viable option to restore cardiac function and enhance their overall quality of life.
John R Doty
Intermountain Medical Center, United States
Trevor Tucker
Dynamic Vascular Resolution Inc., Canada
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Fatima Michelle Villa Jimenez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico
Yoana Tenneth Mancilla Sandoval
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Doppler ultrasound measurement of central artery elasticity: A new natural-frequency framework for cardiovascular risk assessment
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain